Skip to main content
Top
Published in: Pediatric Radiology 12/2016

01-11-2016 | Original Article

Early characteristic radiographic changes in mucolipidosis II

Authors: Lillian M. Lai, Ralph S. Lachman

Published in: Pediatric Radiology | Issue 12/2016

Login to get access

Abstract

Background

Although mucolipidosis type II has similar metabolic abnormalities to those found in all the mucopolysaccharidoses and mucolipidoses, there are distinctive diagnostic radiographic changes of mucolipidosis II in the perinatal/newborn/infant period.

Objective

To describe the early characteristic radiographic changes of mucolipidosis II and to document when these changes manifest and resolve.

Materials and methods

We retrospectively reviewed radiographs and clinical records of 19 cases of mucolipidosis II from the International Skeletal Dysplasia Registry (1971–present; fetal age to 2½ years). A radiologist with special expertise in skeletal dysplasias evaluated the radiographs.

Results

The most common abnormalities were increased vertebral body height (80%, nonspecific), talocalcaneal stippling (86%), periosteal cloaking (74%) and vertebral body rounding (50%). Unreported findings included sacrococcygeal sclerosis (54%) and vertebral body sclerosis (13%). Rickets and hyperparathyroidism-like (pseudohyperparathyroidism) changes (rarely reported) were found in 33% of cases. These changes invariably started in the newborn period and resolved by 1 year of age. The conversion from these early infantile radiographic features to dysostosis multiplex changes occurred in 41% of cases, and within the first year after birth.

Conclusion

Several findings strongly suggest the diagnosis of mucolipidosis II, including cloaking in combination with one or more of the following radiographic criteria: talocalcaneal stippling, sacrococcygeal or generalized vertebral body sclerosis, vertebral body rounding, or rickets/hyperparathyroidism-like changes in the perinatal/newborn/infancy period. These findings are not found in the other two forms of mucolipidosis nor in any of the mucopolysaccharidoses.
Literature
1.
go back to reference Kollmann K, Pestka JM, Kühn SC et al (2013) Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med 5:1871–1886CrossRefPubMedPubMedCentral Kollmann K, Pestka JM, Kühn SC et al (2013) Decreased bone formation and increased osteoclastogenesis cause bone loss in mucolipidosis II. EMBO Mol Med 5:1871–1886CrossRefPubMedPubMedCentral
2.
go back to reference David-Vizcarra G, Briody J, Ault J et al (2010) The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 46:316–322CrossRefPubMedPubMedCentral David-Vizcarra G, Briody J, Ault J et al (2010) The natural history and osteodystrophy of mucolipidosis types II and III. J Paediatr Child Health 46:316–322CrossRefPubMedPubMedCentral
3.
go back to reference Lachman RS, Burton BK, Clarke LA et al (2014) Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. Skeletal Radiol 43:359–369CrossRefPubMedPubMedCentral Lachman RS, Burton BK, Clarke LA et al (2014) Mucopolysaccharidosis IVA (Morquio A syndrome) and VI (Maroteaux-Lamy syndrome): under-recognized and challenging to diagnose. Skeletal Radiol 43:359–369CrossRefPubMedPubMedCentral
4.
go back to reference Cathey SS, Leroy JG, Wood T et al (2010) Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 47:38–48CrossRefPubMed Cathey SS, Leroy JG, Wood T et al (2010) Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 47:38–48CrossRefPubMed
5.
go back to reference Leroy JG, Cathey S, Friez MJ (2012) Mucolipidosis II. In: Ragon RA, Adam MP, Ardinger HH et al (eds) GeneReviews. University of Washington, Seattle, pp 1–24 Leroy JG, Cathey S, Friez MJ (2012) Mucolipidosis II. In: Ragon RA, Adam MP, Ardinger HH et al (eds) GeneReviews. University of Washington, Seattle, pp 1–24
6.
go back to reference Leroy JG, Demars RI (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157:804–806CrossRefPubMed Leroy JG, Demars RI (1967) Mutant enzymatic and cytological phenotypes in cultured human fibroblasts. Science 157:804–806CrossRefPubMed
7.
go back to reference Leroy JG, Spranger JW (1970) I-cell disease. N Engl J Med 283:598–599PubMed Leroy JG, Spranger JW (1970) I-cell disease. N Engl J Med 283:598–599PubMed
8.
go back to reference Maroteaux P, Lamy M (1966) Hurler’s pseudo-polydystrophy. Presse Med 74:2889–2892PubMed Maroteaux P, Lamy M (1966) Hurler’s pseudo-polydystrophy. Presse Med 74:2889–2892PubMed
9.
go back to reference Landing B, Silverman F, Craig J et al (1964) Familial neurovisceral lipidosis: an analysis of eight cases of a syndrome previously reported as ‘Hurler-variant’, ‘Pseudo-Hurler disease’, and ‘Tay-Sachs disease with visceral involvement’. Am J Dis Child 108:503–522CrossRefPubMed Landing B, Silverman F, Craig J et al (1964) Familial neurovisceral lipidosis: an analysis of eight cases of a syndrome previously reported as ‘Hurler-variant’, ‘Pseudo-Hurler disease’, and ‘Tay-Sachs disease with visceral involvement’. Am J Dis Child 108:503–522CrossRefPubMed
10.
go back to reference Leroy JG, Sillence D, Wood T et al (2014) A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain. Eur J Hum Genet 22:594–601CrossRefPubMed Leroy JG, Sillence D, Wood T et al (2014) A novel intermediate mucolipidosis II/IIIalphabeta caused by GNPTAB mutation in the cytosolic N-terminal domain. Eur J Hum Genet 22:594–601CrossRefPubMed
11.
go back to reference Taber P, Gyepes MT, Philippart M et al (1973) Roentgenographic manifestations of Leroy’s I-cell disease. Am J Roentgenol Radium Ther Nucl Med 118:213–221CrossRefPubMed Taber P, Gyepes MT, Philippart M et al (1973) Roentgenographic manifestations of Leroy’s I-cell disease. Am J Roentgenol Radium Ther Nucl Med 118:213–221CrossRefPubMed
12.
go back to reference Lin MH-C, Pitukcheewanont P (2012) Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab 25:191–195PubMed Lin MH-C, Pitukcheewanont P (2012) Mucolipidosis type II (I-cell disease) masquerading as rickets: two case reports and review of literature. J Pediatr Endocrinol Metab 25:191–195PubMed
13.
go back to reference Pazzaglia UE, Beluffi G, Danesino C et al (1989) Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment. Report of two cases. Pediatr Radiol 20:80–84CrossRefPubMed Pazzaglia UE, Beluffi G, Danesino C et al (1989) Neonatal mucolipidosis 2. The spontaneous evolution of early bone lesions and the effect of vitamin D treatment. Report of two cases. Pediatr Radiol 20:80–84CrossRefPubMed
14.
go back to reference Pazzaglia UE, Beluffi G, Campbell JB et al (1989) Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr Radiol 19:406–413CrossRefPubMed Pazzaglia UE, Beluffi G, Campbell JB et al (1989) Mucolipidosis II: correlation between radiological features and histopathology of the bones. Pediatr Radiol 19:406–413CrossRefPubMed
15.
go back to reference Alegra T, Cury G, Todeschini LA et al (2013) Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically? J Pediatr Endocrinol Metab 26:1011–1013CrossRefPubMed Alegra T, Cury G, Todeschini LA et al (2013) Should neonatal hyperparathyroidism associated with mucolipidosis II/III be treated pharmacologically? J Pediatr Endocrinol Metab 26:1011–1013CrossRefPubMed
16.
go back to reference Sathasivam A, Garibaldi L, Murphy R et al (2006) Transient neonatal hyperparathyroidism: a presenting feature of mucolipidosis type II. J Pediatr Endocrinol Metab 19:859–862CrossRefPubMed Sathasivam A, Garibaldi L, Murphy R et al (2006) Transient neonatal hyperparathyroidism: a presenting feature of mucolipidosis type II. J Pediatr Endocrinol Metab 19:859–862CrossRefPubMed
17.
go back to reference Saul RA, Proud V, Taylor HA et al (2005) Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 135:328–332CrossRefPubMed Saul RA, Proud V, Taylor HA et al (2005) Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia. Am J Med Genet A 135:328–332CrossRefPubMed
18.
go back to reference Lachman R, Taybi H (2006) Taybi and Lachman’s radiology of syndromes, metabolic disorders, and skeletal dysplasias, 5th edn. Mosby, Philadelphia Lachman R, Taybi H (2006) Taybi and Lachman’s radiology of syndromes, metabolic disorders, and skeletal dysplasias, 5th edn. Mosby, Philadelphia
Metadata
Title
Early characteristic radiographic changes in mucolipidosis II
Authors
Lillian M. Lai
Ralph S. Lachman
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 12/2016
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3673-0

Other articles of this Issue 12/2016

Pediatric Radiology 12/2016 Go to the issue